Tag Archives: DAA

Treatment as Prevention? Or get to the back of the queue!

Direct-acting anti-viral (DAAs) therapies have changed the hepatitis C landscape.Rather than ‘can we cure?’, the question is now ‘who should we cure first?’ Continue reading

Posted in Hepatitis C, Injection Drug Use, Publications and Tools, Research | Tagged , , , | 1 Comment